A high-throughput assay of NK cell activity in whole blood and its clinical application
•We demonstrated a simple assay of NK cell activity from whole blood.•The measurement of secreted IFN-γ from NK cell enables high-throughput screening.•The NKA assay was validated by clinical results of colorectal cancer patients. Natural killer (NK) cells are lymphocytes of the innate immune system...
Saved in:
| Published in | Biochemical and biophysical research communications Vol. 445; no. 3; pp. 584 - 590 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
14.03.2014
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | •We demonstrated a simple assay of NK cell activity from whole blood.•The measurement of secreted IFN-γ from NK cell enables high-throughput screening.•The NKA assay was validated by clinical results of colorectal cancer patients.
Natural killer (NK) cells are lymphocytes of the innate immune system and have the ability to kill tumor cells and virus-infected cells without prior sensitization. Malignant tumors and viruses have developed, however, strategies to suppress NK cells to escape from their responses. Thus, the evaluation of NK cell activity (NKA) could be invaluable to estimate the status and the outcome of cancers, viral infections, and immune-mediated diseases. Established methods that measure NKA, such as 51Cr release assay and CD107a degranulation assay, may be used to determine NK cell function, but they are complicated and time-consuming because they require isolation of peripheral blood mononuclear cells (PBMC) or NK cells. In some cases these assays require hazardous material such as radioactive isotopes. To overcome these difficulties, we developed a simple assay that uses whole blood instead of PBMC or isolated NK cells. This novel assay is suitable for high-throughput screening and the monitoring of diseases, because it employs serum of ex vivo stimulated whole blood to detect interferon (IFN)-γ secreted from NK cells as an indicator of NKA. After the stimulation of NK cells, the determination of IFNγ concentration in serum samples by enzyme-linked immunosorbent assay (ELISA) provided a swift, uncomplicated, and high-throughput assay of NKA ex vivo. The NKA results microsatellite stable (MSS) colorectal cancer patients was showed significantly lower NKA, 263.6±54.5pg/mL compared with healthy subjects, 867.5±50.2pg/mL (p value <0.0001). Therefore, the NKA could be utilized as a supportive diagnostic marker for microsatellite stable (MSS) colorectal cancer. |
|---|---|
| AbstractList | Natural killer (NK) cells are lymphocytes of the innate immune system and have the ability to kill tumor cells and virus-infected cells without prior sensitization. Malignant tumors and viruses have developed, however, strategies to suppress NK cells to escape from their responses. Thus, the evaluation of NK cell activity (NKA) could be invaluable to estimate the status and the outcome of cancers, viral infections, and immune-mediated diseases. Established methods that measure NKA, such as (51)Cr release assay and CD107a degranulation assay, may be used to determine NK cell function, but they are complicated and time-consuming because they require isolation of peripheral blood mononuclear cells (PBMC) or NK cells. In some cases these assays require hazardous material such as radioactive isotopes. To overcome these difficulties, we developed a simple assay that uses whole blood instead of PBMC or isolated NK cells. This novel assay is suitable for high-throughput screening and the monitoring of diseases, because it employs serum of ex vivo stimulated whole blood to detect interferon (IFN)-γ secreted from NK cells as an indicator of NKA. After the stimulation of NK cells, the determination of IFNγ concentration in serum samples by enzyme-linked immunosorbent assay (ELISA) provided a swift, uncomplicated, and high-throughput assay of NKA ex vivo. The NKA results microsatellite stable (MSS) colorectal cancer patients was showed significantly lower NKA, 263.6 ± 54.5 pg/mL compared with healthy subjects, 867.5 ± 50.2 pg/mL (p value <0.0001). Therefore, the NKA could be utilized as a supportive diagnostic marker for microsatellite stable (MSS) colorectal cancer.Natural killer (NK) cells are lymphocytes of the innate immune system and have the ability to kill tumor cells and virus-infected cells without prior sensitization. Malignant tumors and viruses have developed, however, strategies to suppress NK cells to escape from their responses. Thus, the evaluation of NK cell activity (NKA) could be invaluable to estimate the status and the outcome of cancers, viral infections, and immune-mediated diseases. Established methods that measure NKA, such as (51)Cr release assay and CD107a degranulation assay, may be used to determine NK cell function, but they are complicated and time-consuming because they require isolation of peripheral blood mononuclear cells (PBMC) or NK cells. In some cases these assays require hazardous material such as radioactive isotopes. To overcome these difficulties, we developed a simple assay that uses whole blood instead of PBMC or isolated NK cells. This novel assay is suitable for high-throughput screening and the monitoring of diseases, because it employs serum of ex vivo stimulated whole blood to detect interferon (IFN)-γ secreted from NK cells as an indicator of NKA. After the stimulation of NK cells, the determination of IFNγ concentration in serum samples by enzyme-linked immunosorbent assay (ELISA) provided a swift, uncomplicated, and high-throughput assay of NKA ex vivo. The NKA results microsatellite stable (MSS) colorectal cancer patients was showed significantly lower NKA, 263.6 ± 54.5 pg/mL compared with healthy subjects, 867.5 ± 50.2 pg/mL (p value <0.0001). Therefore, the NKA could be utilized as a supportive diagnostic marker for microsatellite stable (MSS) colorectal cancer. Natural killer (NK) cells are lymphocytes of the innate immune system and have the ability to kill tumor cells and virus-infected cells without prior sensitization. Malignant tumors and viruses have developed, however, strategies to suppress NK cells to escape from their responses. Thus, the evaluation of NK cell activity (NKA) could be invaluable to estimate the status and the outcome of cancers, viral infections, and immune-mediated diseases. Established methods that measure NKA, such as (51)Cr release assay and CD107a degranulation assay, may be used to determine NK cell function, but they are complicated and time-consuming because they require isolation of peripheral blood mononuclear cells (PBMC) or NK cells. In some cases these assays require hazardous material such as radioactive isotopes. To overcome these difficulties, we developed a simple assay that uses whole blood instead of PBMC or isolated NK cells. This novel assay is suitable for high-throughput screening and the monitoring of diseases, because it employs serum of ex vivo stimulated whole blood to detect interferon (IFN)-γ secreted from NK cells as an indicator of NKA. After the stimulation of NK cells, the determination of IFNγ concentration in serum samples by enzyme-linked immunosorbent assay (ELISA) provided a swift, uncomplicated, and high-throughput assay of NKA ex vivo. The NKA results microsatellite stable (MSS) colorectal cancer patients was showed significantly lower NKA, 263.6 ± 54.5 pg/mL compared with healthy subjects, 867.5 ± 50.2 pg/mL (p value <0.0001). Therefore, the NKA could be utilized as a supportive diagnostic marker for microsatellite stable (MSS) colorectal cancer. Natural killer (NK) cells are lymphocytes of the innate immune system and have the ability to kill tumor cells and virus-infected cells without prior sensitization. Malignant tumors and viruses have developed, however, strategies to suppress NK cells to escape from their responses. Thus, the evaluation of NK cell activity (NKA) could be invaluable to estimate the status and the outcome of cancers, viral infections, and immune-mediated diseases. Established methods that measure NKA, such as 51Cr release assay and CD107a degranulation assay, may be used to determine NK cell function, but they are complicated and time-consuming because they require isolation of peripheral blood mononuclear cells (PBMC) or NK cells. In some cases these assays require hazardous material such as radioactive isotopes. To overcome these difficulties, we developed a simple assay that uses whole blood instead of PBMC or isolated NK cells. This novel assay is suitable for high-throughput screening and the monitoring of diseases, because it employs serum of ex vivo stimulated whole blood to detect interferon (IFN)-γ secreted from NK cells as an indicator of NKA. After the stimulation of NK cells, the determination of IFNγ concentration in serum samples by enzyme-linked immunosorbent assay (ELISA) provided a swift, uncomplicated, and high-throughput assay of NKA ex vivo. The NKA results microsatellite stable (MSS) colorectal cancer patients was showed significantly lower NKA, 263.6±54.5pg/mL compared with healthy subjects, 867.5±50.2pg/mL (p value <0.0001). Therefore, the NKA could be utilized as a supportive diagnostic marker for microsatellite stable (MSS) colorectal cancer. •We demonstrated a simple assay of NK cell activity from whole blood.•The measurement of secreted IFN-γ from NK cell enables high-throughput screening.•The NKA assay was validated by clinical results of colorectal cancer patients. Natural killer (NK) cells are lymphocytes of the innate immune system and have the ability to kill tumor cells and virus-infected cells without prior sensitization. Malignant tumors and viruses have developed, however, strategies to suppress NK cells to escape from their responses. Thus, the evaluation of NK cell activity (NKA) could be invaluable to estimate the status and the outcome of cancers, viral infections, and immune-mediated diseases. Established methods that measure NKA, such as 51Cr release assay and CD107a degranulation assay, may be used to determine NK cell function, but they are complicated and time-consuming because they require isolation of peripheral blood mononuclear cells (PBMC) or NK cells. In some cases these assays require hazardous material such as radioactive isotopes. To overcome these difficulties, we developed a simple assay that uses whole blood instead of PBMC or isolated NK cells. This novel assay is suitable for high-throughput screening and the monitoring of diseases, because it employs serum of ex vivo stimulated whole blood to detect interferon (IFN)-γ secreted from NK cells as an indicator of NKA. After the stimulation of NK cells, the determination of IFNγ concentration in serum samples by enzyme-linked immunosorbent assay (ELISA) provided a swift, uncomplicated, and high-throughput assay of NKA ex vivo. The NKA results microsatellite stable (MSS) colorectal cancer patients was showed significantly lower NKA, 263.6±54.5pg/mL compared with healthy subjects, 867.5±50.2pg/mL (p value <0.0001). Therefore, the NKA could be utilized as a supportive diagnostic marker for microsatellite stable (MSS) colorectal cancer. Graphical abstract: - Highlights: • We demonstrated a simple assay of NK cell activity from whole blood. • The measurement of secreted IFN-γ from NK cell enables high-throughput screening. • The NKA assay was validated by clinical results of colorectal cancer patients. - Abstract: Natural killer (NK) cells are lymphocytes of the innate immune system and have the ability to kill tumor cells and virus-infected cells without prior sensitization. Malignant tumors and viruses have developed, however, strategies to suppress NK cells to escape from their responses. Thus, the evaluation of NK cell activity (NKA) could be invaluable to estimate the status and the outcome of cancers, viral infections, and immune-mediated diseases. Established methods that measure NKA, such as {sup 51}Cr release assay and CD107a degranulation assay, may be used to determine NK cell function, but they are complicated and time-consuming because they require isolation of peripheral blood mononuclear cells (PBMC) or NK cells. In some cases these assays require hazardous material such as radioactive isotopes. To overcome these difficulties, we developed a simple assay that uses whole blood instead of PBMC or isolated NK cells. This novel assay is suitable for high-throughput screening and the monitoring of diseases, because it employs serum of ex vivo stimulated whole blood to detect interferon (IFN)-γ secreted from NK cells as an indicator of NKA. After the stimulation of NK cells, the determination of IFNγ concentration in serum samples by enzyme-linked immunosorbent assay (ELISA) provided a swift, uncomplicated, and high-throughput assay of NKA ex vivo. The NKA results microsatellite stable (MSS) colorectal cancer patients was showed significantly lower NKA, 263.6 ± 54.5 pg/mL compared with healthy subjects, 867.5 ± 50.2 pg/mL (p value <0.0001). Therefore, the NKA could be utilized as a supportive diagnostic marker for microsatellite stable (MSS) colorectal cancer. |
| Author | Cho, Sunjung Lee, Heyja Yoon, Joo Chun Kim, Im-kyung Cha, Junhoe Lee, Jae Myun Lee, Saet-byul Lee, Choong Hwan Youn, Dong-Ye Kim, Jongsun Lee, Kang Young Lee, Hyo Joon Park, Sang Woo |
| Author_xml | – sequence: 1 givenname: Saet-byul surname: Lee fullname: Lee, Saet-byul organization: Department of Microbiology and Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea – sequence: 2 givenname: Junhoe surname: Cha fullname: Cha, Junhoe organization: ATGen Co. Ltd., Sungnam, Republic of Korea – sequence: 3 givenname: Im-kyung surname: Kim fullname: Kim, Im-kyung organization: Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea – sequence: 4 givenname: Joo Chun surname: Yoon fullname: Yoon, Joo Chun organization: Department of Microbiology, Ewha Womans University School of Medicine, Seoul, Republic of Korea – sequence: 5 givenname: Hyo Joon surname: Lee fullname: Lee, Hyo Joon organization: Department of Microbiology and Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea – sequence: 6 givenname: Sang Woo surname: Park fullname: Park, Sang Woo organization: ATGen Co. Ltd., Sungnam, Republic of Korea – sequence: 7 givenname: Sunjung surname: Cho fullname: Cho, Sunjung organization: ATGen Co. Ltd., Sungnam, Republic of Korea – sequence: 8 givenname: Dong-Ye surname: Youn fullname: Youn, Dong-Ye organization: ATGen Co. Ltd., Sungnam, Republic of Korea – sequence: 9 givenname: Heyja surname: Lee fullname: Lee, Heyja organization: ATGen Co. Ltd., Sungnam, Republic of Korea – sequence: 10 givenname: Choong Hwan surname: Lee fullname: Lee, Choong Hwan organization: ATGen Co. Ltd., Sungnam, Republic of Korea – sequence: 11 givenname: Jae Myun surname: Lee fullname: Lee, Jae Myun organization: Department of Microbiology and Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea – sequence: 12 givenname: Kang Young surname: Lee fullname: Lee, Kang Young email: kylee117@yuhs.ac organization: Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea – sequence: 13 givenname: Jongsun surname: Kim fullname: Kim, Jongsun email: jkim63@yuhs.ac organization: Department of Microbiology and Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24561245$$D View this record in MEDLINE/PubMed https://www.osti.gov/biblio/22416314$$D View this record in Osti.gov |
| BookMark | eNqFkUFv1DAQhS1URLeFP8ABWeLCJWHG63gTiUtVlRZRwQUEN8t2nMarrL3YTtH-exy2vXAoF9uyvvc0894ZOfHBW0JeI9QIKN5va62jqRkgr4HVwOEZWSF0UDEEfkJWACAq1uHPU3KW0hYAkYvuBTllvBFYjhX5cUFHdzdWeYxhvhv3c6YqJXWgYaBfPlNjp4kqk929ywfqPP09hslSPYXQU-V76nKiZnLeGVXA_X4qj-yCf0meD2pK9tXDfU6-f7z6dnlT3X69_nR5cVsZLjBXotGs4VoNjeCMdxsQ656JdrBNa8QaodcaN0JvTMOFbgc9wKZXmhtd_rqOd-tz8vboG1J2MhmXrRlN8N6aLBnjWFx4od4dqX0Mv2absty5tOymvA1zktiWKVDwDv6PNtBy5LzBgr55QGe9s73cR7dT8SAf0y1AewRMDClFO8gy3994clRukghyKVJu5VKkXIqUwGQpskjZP9JH9ydFH44iWxK_dzYugVhvbO_ikkcf3FPyP6pntGw |
| CitedBy_id | crossref_primary_10_15430_JCP_2020_25_1_13 crossref_primary_10_1038_s41416_023_02285_z crossref_primary_10_1021_acsami_1c08986 crossref_primary_10_3390_ijms20215413 crossref_primary_10_3390_ijms25084561 crossref_primary_10_1016_j_tranon_2019_04_002 crossref_primary_10_3389_fimmu_2024_1465953 crossref_primary_10_3389_fimmu_2020_01851 crossref_primary_10_4236_jbm_2021_95004 crossref_primary_10_3390_jcm12124027 crossref_primary_10_3390_ijms241512505 crossref_primary_10_37349_ei_2024_00159 crossref_primary_10_1016_j_ctim_2022_102825 crossref_primary_10_1097_MD_0000000000017228 crossref_primary_10_1021_acssensors_0c02138 crossref_primary_10_1016_j_humimm_2024_111185 crossref_primary_10_1186_s12859_019_2636_5 crossref_primary_10_3390_cancers11101534 crossref_primary_10_1111_jgh_14028 crossref_primary_10_1016_j_anaerobe_2020_102234 crossref_primary_10_1016_j_bios_2024_116512 crossref_primary_10_1016_j_tranon_2024_102198 crossref_primary_10_1371_journal_pone_0193299 crossref_primary_10_1016_j_clim_2022_108962 crossref_primary_10_3390_ijerph19095463 crossref_primary_10_1007_s10787_017_0395_3 crossref_primary_10_1053_j_gastro_2017_06_009 crossref_primary_10_3343_lmo_2018_8_2_41 crossref_primary_10_1002_jcla_22640 crossref_primary_10_18632_oncotarget_19712 crossref_primary_10_1245_s10434_018_6691_3 crossref_primary_10_2174_1573394717666210223111332 crossref_primary_10_1111_jgh_15265 crossref_primary_10_3389_fimmu_2024_1376421 crossref_primary_10_22246_jikm_2018_39_4_471 crossref_primary_10_1177_2472555218797078 crossref_primary_10_3390_diagnostics12020448 crossref_primary_10_1016_j_jpha_2020_02_005 crossref_primary_10_1016_j_humimm_2016_05_022 crossref_primary_10_3349_ymj_2018_59_4_554 crossref_primary_10_1186_s12871_023_02011_5 crossref_primary_10_1038_s41577_021_00566_3 crossref_primary_10_1111_jdi_13002 crossref_primary_10_1177_1534735417717789 crossref_primary_10_3390_jcm11113014 crossref_primary_10_3389_fimmu_2021_594356 crossref_primary_10_1002_smll_202302809 crossref_primary_10_3390_brainsci12091144 crossref_primary_10_47429_lmo_2023_13_4_349 crossref_primary_10_1080_0284186X_2020_1791358 crossref_primary_10_1186_s12575_015_0026_6 crossref_primary_10_3390_ijms21218112 crossref_primary_10_3343_lmo_2018_8_1_15 crossref_primary_10_3340_jkns_2020_0339 |
| Cites_doi | 10.1038/nrc928 10.1007/s00262-011-1122-3 10.4049/jimmunol.164.12.6244 10.1016/S0002-9343(98)00155-7 10.1038/319675a0 10.1111/j.1572-0241.2001.03535.x 10.1038/nri2808 10.1136/bmj.329.7477.1283 10.1038/ni.1962 10.1159/000325265 10.1016/j.jim.2008.11.006 10.1016/S0002-9440(10)63994-6 10.1016/S0140-6736(00)03231-1 10.1038/nri2073 10.1182/blood.V99.8.2694 10.1046/j.1365-2249.1997.4581355.x 10.1086/368222 10.1016/j.jim.2004.08.008 10.1038/ni1138 10.1007/BF00295186 10.1002/sim.1013 10.1207/S15324826AN0801_7 10.1006/meth.1996.0037 10.1111/j.1365-3083.2011.02667.x 10.1002/1521-4141(200111)31:11<3355::AID-IMMU3355>3.0.CO;2-D 10.6026/97320630001363 |
| ContentType | Journal Article |
| Copyright | 2014 Elsevier Inc. Copyright © 2014 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2014 Elsevier Inc. – notice: Copyright © 2014 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 OTOTI |
| DOI | 10.1016/j.bbrc.2014.02.040 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic OSTI.GOV |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE AGRICOLA |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry Biology |
| EISSN | 1090-2104 |
| EndPage | 590 |
| ExternalDocumentID | 22416314 24561245 10_1016_j_bbrc_2014_02_040 S0006291X14002927 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- --K --M -~X .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 6J9 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACNCT ACRLP ADBBV ADEZE ADIYS ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 D0L DM4 DOVZS EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W K-O KOM L7B LG5 LX2 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RIG RNS ROL RPZ SCC SDF SDG SDP SES SPCBC SSU SSZ T5K TWZ WH7 XPP XSW ZA5 ZMT ~02 ~G- .55 .GJ .HR 1CY 3O- 9M8 AAHBH AAQXK AATTM AAXKI AAYJJ AAYWO AAYXX ABDPE ABEFU ABWVN ACKIV ACRPL ACVFH ADCNI ADFGL ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRDE AGRNS AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CAG CITATION COF FEDTE FGOYB G-2 HLW HVGLF HZ~ MVM OHT R2- SBG SEW SSH UQL WUQ X7M Y6R ZGI ZKB ~KM CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 AALMO AAPBV ABPIF ABQIS EFJIC OTOTI |
| ID | FETCH-LOGICAL-c461t-65b254baf5642497063d268fe58c6310dbb176b7c546b8fbf07dab4cb6b799493 |
| IEDL.DBID | .~1 |
| ISSN | 0006-291X 1090-2104 |
| IngestDate | Fri May 19 00:35:14 EDT 2023 Fri Jul 11 01:31:59 EDT 2025 Fri Jul 11 01:31:16 EDT 2025 Wed Feb 19 01:57:15 EST 2025 Tue Jul 01 03:09:56 EDT 2025 Thu Apr 24 23:11:25 EDT 2025 Fri Feb 23 02:34:20 EST 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | High-throughput screening IFN-γ Simple assay NK cell activity ELISA |
| Language | English |
| License | Copyright © 2014 Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c461t-65b254baf5642497063d268fe58c6310dbb176b7c546b8fbf07dab4cb6b799493 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://ir.ymlib.yonsei.ac.kr/handle/22282913/98648 |
| PMID | 24561245 |
| PQID | 1508414451 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | osti_scitechconnect_22416314 proquest_miscellaneous_1825416490 proquest_miscellaneous_1508414451 pubmed_primary_24561245 crossref_citationtrail_10_1016_j_bbrc_2014_02_040 crossref_primary_10_1016_j_bbrc_2014_02_040 elsevier_sciencedirect_doi_10_1016_j_bbrc_2014_02_040 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-03-14 |
| PublicationDateYYYYMMDD | 2014-03-14 |
| PublicationDate_xml | – month: 03 year: 2014 text: 2014-03-14 day: 14 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Biochemical and biophysical research communications |
| PublicationTitleAlternate | Biochem Biophys Res Commun |
| PublicationYear | 2014 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Alexander, Watanabe, Wu, Rashid, Li, Hamilton (b0115) 2001; 158 Kottilil, Chun, Moir, Liu, McLaughlin, Hallahan, Maldarelli, Corey, Fauci (b0070) 2003; 187 Prolo, Chiappelli, Angeli, Dovio, Perotti, Pautasso, Sartori, Saba, Mussino, Fraccalini, Fantó, Mocellini, Rosso, Grasso (b0080) 2007; 1 Moffett, Regan, Braude (b0090) 2004; 329 Hawkins (b0120) 2002; 21 Flavell, Sanjabi, Wrzesinski, Licona-Limon (b0140) 2010; 10 Alter, Malenfant, Altfeld (b0100) 2004; 294 Arkwright, Abinun, Cant (b0075) 2002; 99 Dowell, Oldham, Bhatt, Lee, Searle (b0110) 2012; 61 Langers, Renoux, Thiry, Delvenne, Jacobs (b0015) 2012; 6 Whiteside, Friberg (b0045) 1998; 105 Claus, Greil, Watzl (b0105) 2009; 341 Bryceson, Chiang, Darmanin, Fauriat, Schlums, Theorell, Wood (b0010) 2011; 3 Takeuchi, Maehara, Tokunaga, Koga, Kakeji, Sugimachi (b0060) 2001; 96 Nagel, Collins (b0130) 1981; 41 Ljunggren, Malmberg (b0025) 2007; 7 Smyth, Hayakawa, Takeda, Yagita (b0030) 2002; 2 Corado, Toro, Rivera, Bianco, Deibis, De Sanctis (b0065) 1997; 109 Konjevic, Spuzic (b0050) 1993; 40 Martin-Fontecha, Thomsen, Brett, Gerard, Lipp, Lanzavecchia, Sallusto (b0040) 2004; 5 Yu, Caudell, Smid, Grimm (b0035) 2000; 164 Spits, Di Santo (b0005) 2011; 12 Karre, Ljunggren, Piontek, Kiessling (b0020) 1986; 319 Friberg, Bryant, Whiteside (b0150) 1996; 9 Patarca-Montero, Antoni, Fletcher, Klimas (b0085) 2001; 8 Valiathan, Lewis, Melillo, Leonard, Ali, Asthana (b0095) 2012; 75 Thornton, Kuhn, Finkelman, Hirsch (b0135) 2001; 31 Imai, Matsuyama, Miyake, Suga, Nakachi (b0145) 2000; 356 Tarle, Kraljic, Kastelan (b0055) 1993; 21 Kawasaki-Oyama, Braile, Caldas, Leal, Goloni-Bertollo, Pavarino-Bertelli, Abbud (b0125) 2008; 23 Friberg (10.1016/j.bbrc.2014.02.040_b0150) 1996; 9 Hawkins (10.1016/j.bbrc.2014.02.040_b0120) 2002; 21 Konjevic (10.1016/j.bbrc.2014.02.040_b0050) 1993; 40 Smyth (10.1016/j.bbrc.2014.02.040_b0030) 2002; 2 Ljunggren (10.1016/j.bbrc.2014.02.040_b0025) 2007; 7 Claus (10.1016/j.bbrc.2014.02.040_b0105) 2009; 341 Spits (10.1016/j.bbrc.2014.02.040_b0005) 2011; 12 Corado (10.1016/j.bbrc.2014.02.040_b0065) 1997; 109 Imai (10.1016/j.bbrc.2014.02.040_b0145) 2000; 356 Alexander (10.1016/j.bbrc.2014.02.040_b0115) 2001; 158 Valiathan (10.1016/j.bbrc.2014.02.040_b0095) 2012; 75 Patarca-Montero (10.1016/j.bbrc.2014.02.040_b0085) 2001; 8 Moffett (10.1016/j.bbrc.2014.02.040_b0090) 2004; 329 Dowell (10.1016/j.bbrc.2014.02.040_b0110) 2012; 61 Takeuchi (10.1016/j.bbrc.2014.02.040_b0060) 2001; 96 Kottilil (10.1016/j.bbrc.2014.02.040_b0070) 2003; 187 Prolo (10.1016/j.bbrc.2014.02.040_b0080) 2007; 1 Nagel (10.1016/j.bbrc.2014.02.040_b0130) 1981; 41 Alter (10.1016/j.bbrc.2014.02.040_b0100) 2004; 294 Whiteside (10.1016/j.bbrc.2014.02.040_b0045) 1998; 105 Bryceson (10.1016/j.bbrc.2014.02.040_b0010) 2011; 3 Langers (10.1016/j.bbrc.2014.02.040_b0015) 2012; 6 Karre (10.1016/j.bbrc.2014.02.040_b0020) 1986; 319 Yu (10.1016/j.bbrc.2014.02.040_b0035) 2000; 164 Arkwright (10.1016/j.bbrc.2014.02.040_b0075) 2002; 99 Kawasaki-Oyama (10.1016/j.bbrc.2014.02.040_b0125) 2008; 23 Martin-Fontecha (10.1016/j.bbrc.2014.02.040_b0040) 2004; 5 Tarle (10.1016/j.bbrc.2014.02.040_b0055) 1993; 21 Thornton (10.1016/j.bbrc.2014.02.040_b0135) 2001; 31 Flavell (10.1016/j.bbrc.2014.02.040_b0140) 2010; 10 |
| References_xml | – volume: 12 start-page: 21 year: 2011 end-page: 27 ident: b0005 article-title: The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling publication-title: Nat Immunol – volume: 3 start-page: 216 year: 2011 end-page: 226 ident: b0010 article-title: Molecular mechanisms of natural killer cell activation publication-title: J Innate Immun – volume: 31 start-page: 3355 year: 2001 end-page: 3360 ident: b0135 article-title: NK cells secrete high levels of IFN-gamma in response to in vivo administration of IL-2 publication-title: Eur J Immunol – volume: 1 start-page: 363 year: 2007 end-page: 366 ident: b0080 article-title: Physiologic modulation of natural killer cell activity as an index of Alzheimer′s disease progression publication-title: Bioinformation – volume: 5 start-page: 1260 year: 2004 end-page: 1265 ident: b0040 article-title: Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming publication-title: Nat Immunol – volume: 10 start-page: 554 year: 2010 end-page: 567 ident: b0140 article-title: The polarization of immune cells in the tumour environment by TGFbeta publication-title: Nat Rev Immunol – volume: 109 start-page: 451 year: 1997 end-page: 457 ident: b0065 article-title: Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection publication-title: Clin Exp Immunol – volume: 7 start-page: 329 year: 2007 end-page: 339 ident: b0025 article-title: Prospects for the use of NK cells in immunotherapy of human cancer publication-title: Nat Rev Immunol – volume: 164 start-page: 6244 year: 2000 end-page: 6251 ident: b0035 article-title: IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway publication-title: J Immunol – volume: 356 start-page: 1795 year: 2000 end-page: 1799 ident: b0145 article-title: Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence. an 11-year follow-up study of a general population publication-title: Lancet – volume: 105 start-page: 27S year: 1998 end-page: 34S ident: b0045 article-title: Natural killer cells and natural killer cell activity in chronic fatigue syndrome publication-title: Am J Med – volume: 294 start-page: 15 year: 2004 end-page: 22 ident: b0100 article-title: CD107a as a functional marker for the identification of natural killer cell activity publication-title: J Immunol Methods – volume: 329 start-page: 1283 year: 2004 end-page: 1285 ident: b0090 article-title: Natural killer cells, miscarriage, and infertility publication-title: BMJ – volume: 23 start-page: 29 year: 2008 end-page: 34 ident: b0125 article-title: Filho M publication-title: Blood mesenchymal stem cell culture from the umbilical cord with and without Ficoll-Paque density gradient method, Rev Bras Cir Cardiovasc – volume: 75 start-page: 455 year: 2012 end-page: 462 ident: b0095 article-title: Evaluation of a Flow Cytometry-Based Assay for Natural Killer Cell Activity in Clinical Settings publication-title: Scand J Immunol – volume: 21 start-page: 17 year: 1993 end-page: 21 ident: b0055 article-title: Comparison between NK cell activity and prostate cancer stage and grade in untreated patients: correlation with tumor markers and hormonal serotest data publication-title: Urol Res – volume: 9 start-page: 316 year: 1996 end-page: 326 ident: b0150 article-title: Measurements of Natural Killer (NK) Activity and NK-Cell Quantification publication-title: Methods – volume: 96 start-page: 574 year: 2001 end-page: 578 ident: b0060 article-title: Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis publication-title: Am J Gastroenterol – volume: 158 start-page: 527 year: 2001 end-page: 536 ident: b0115 article-title: Histopathological Identification of Colon Cancer with Microsatellite Instability publication-title: Am J Pathol – volume: 21 start-page: 1913 year: 2002 end-page: 1935 ident: b0120 article-title: Diagnostics for conformity of paired quantitative measurements publication-title: Stat Med – volume: 319 start-page: 675 year: 1986 end-page: 678 ident: b0020 article-title: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy publication-title: Nature – volume: 341 start-page: 154 year: 2009 end-page: 164 ident: b0105 article-title: Comprehensive analysis of NK cell function in whole blood samples publication-title: J Immunol Methods – volume: 6 start-page: 73 year: 2012 end-page: 82 ident: b0015 article-title: Natural killer cells: role in local tumor growth and metastasis publication-title: Biologics – volume: 40 start-page: 81 year: 1993 end-page: 85 ident: b0050 article-title: Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer publication-title: Neoplasma – volume: 41 start-page: 2284 year: 1981 end-page: 2288 ident: b0130 article-title: A. WH., Spontaneous or natural killer cytotoxicity of K562 erythroleukemic cells in normal patients publication-title: Cancer Res – volume: 187 start-page: 1038 year: 2003 end-page: 1045 ident: b0070 article-title: Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function publication-title: J Infect Dis – volume: 61 start-page: 615 year: 2012 end-page: 628 ident: b0110 article-title: Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4–1BBL and IL-12 publication-title: Cancer Immunol Immunother – volume: 99 start-page: 2694 year: 2002 end-page: 2702 ident: b0075 article-title: Autoimmunity in human primary immunodeficiency diseases publication-title: Blood – volume: 8 start-page: 51 year: 2001 end-page: 64 ident: b0085 article-title: Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors publication-title: Appl Neuropsychol – volume: 2 start-page: 850 year: 2002 end-page: 861 ident: b0030 article-title: New aspects of natural-killer-cell surveillance and therapy of cancer publication-title: Nat Rev Cancer – volume: 2 start-page: 850 year: 2002 ident: 10.1016/j.bbrc.2014.02.040_b0030 article-title: New aspects of natural-killer-cell surveillance and therapy of cancer publication-title: Nat Rev Cancer doi: 10.1038/nrc928 – volume: 61 start-page: 615 year: 2012 ident: 10.1016/j.bbrc.2014.02.040_b0110 article-title: Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4–1BBL and IL-12 publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-011-1122-3 – volume: 164 start-page: 6244 year: 2000 ident: 10.1016/j.bbrc.2014.02.040_b0035 article-title: IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway publication-title: J Immunol doi: 10.4049/jimmunol.164.12.6244 – volume: 105 start-page: 27S year: 1998 ident: 10.1016/j.bbrc.2014.02.040_b0045 article-title: Natural killer cells and natural killer cell activity in chronic fatigue syndrome publication-title: Am J Med doi: 10.1016/S0002-9343(98)00155-7 – volume: 319 start-page: 675 year: 1986 ident: 10.1016/j.bbrc.2014.02.040_b0020 article-title: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy publication-title: Nature doi: 10.1038/319675a0 – volume: 96 start-page: 574 year: 2001 ident: 10.1016/j.bbrc.2014.02.040_b0060 article-title: Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2001.03535.x – volume: 10 start-page: 554 year: 2010 ident: 10.1016/j.bbrc.2014.02.040_b0140 article-title: The polarization of immune cells in the tumour environment by TGFbeta publication-title: Nat Rev Immunol doi: 10.1038/nri2808 – volume: 329 start-page: 1283 year: 2004 ident: 10.1016/j.bbrc.2014.02.040_b0090 article-title: Natural killer cells, miscarriage, and infertility publication-title: BMJ doi: 10.1136/bmj.329.7477.1283 – volume: 12 start-page: 21 year: 2011 ident: 10.1016/j.bbrc.2014.02.040_b0005 article-title: The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling publication-title: Nat Immunol doi: 10.1038/ni.1962 – volume: 3 start-page: 216 year: 2011 ident: 10.1016/j.bbrc.2014.02.040_b0010 article-title: Molecular mechanisms of natural killer cell activation publication-title: J Innate Immun doi: 10.1159/000325265 – volume: 6 start-page: 73 year: 2012 ident: 10.1016/j.bbrc.2014.02.040_b0015 article-title: Natural killer cells: role in local tumor growth and metastasis publication-title: Biologics – volume: 341 start-page: 154 year: 2009 ident: 10.1016/j.bbrc.2014.02.040_b0105 article-title: Comprehensive analysis of NK cell function in whole blood samples publication-title: J Immunol Methods doi: 10.1016/j.jim.2008.11.006 – volume: 23 start-page: 29 year: 2008 ident: 10.1016/j.bbrc.2014.02.040_b0125 article-title: Filho M publication-title: Blood mesenchymal stem cell culture from the umbilical cord with and without Ficoll-Paque density gradient method, Rev Bras Cir Cardiovasc – volume: 41 start-page: 2284 year: 1981 ident: 10.1016/j.bbrc.2014.02.040_b0130 article-title: A. WH., Spontaneous or natural killer cytotoxicity of K562 erythroleukemic cells in normal patients publication-title: Cancer Res – volume: 158 start-page: 527 year: 2001 ident: 10.1016/j.bbrc.2014.02.040_b0115 article-title: Histopathological Identification of Colon Cancer with Microsatellite Instability publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)63994-6 – volume: 356 start-page: 1795 year: 2000 ident: 10.1016/j.bbrc.2014.02.040_b0145 article-title: Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence. an 11-year follow-up study of a general population publication-title: Lancet doi: 10.1016/S0140-6736(00)03231-1 – volume: 7 start-page: 329 year: 2007 ident: 10.1016/j.bbrc.2014.02.040_b0025 article-title: Prospects for the use of NK cells in immunotherapy of human cancer publication-title: Nat Rev Immunol doi: 10.1038/nri2073 – volume: 99 start-page: 2694 year: 2002 ident: 10.1016/j.bbrc.2014.02.040_b0075 article-title: Autoimmunity in human primary immunodeficiency diseases publication-title: Blood doi: 10.1182/blood.V99.8.2694 – volume: 109 start-page: 451 year: 1997 ident: 10.1016/j.bbrc.2014.02.040_b0065 article-title: Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection publication-title: Clin Exp Immunol doi: 10.1046/j.1365-2249.1997.4581355.x – volume: 187 start-page: 1038 year: 2003 ident: 10.1016/j.bbrc.2014.02.040_b0070 article-title: Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function publication-title: J Infect Dis doi: 10.1086/368222 – volume: 294 start-page: 15 year: 2004 ident: 10.1016/j.bbrc.2014.02.040_b0100 article-title: CD107a as a functional marker for the identification of natural killer cell activity publication-title: J Immunol Methods doi: 10.1016/j.jim.2004.08.008 – volume: 5 start-page: 1260 year: 2004 ident: 10.1016/j.bbrc.2014.02.040_b0040 article-title: Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming publication-title: Nat Immunol doi: 10.1038/ni1138 – volume: 40 start-page: 81 year: 1993 ident: 10.1016/j.bbrc.2014.02.040_b0050 article-title: Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer publication-title: Neoplasma – volume: 21 start-page: 17 year: 1993 ident: 10.1016/j.bbrc.2014.02.040_b0055 article-title: Comparison between NK cell activity and prostate cancer stage and grade in untreated patients: correlation with tumor markers and hormonal serotest data publication-title: Urol Res doi: 10.1007/BF00295186 – volume: 21 start-page: 1913 year: 2002 ident: 10.1016/j.bbrc.2014.02.040_b0120 article-title: Diagnostics for conformity of paired quantitative measurements publication-title: Stat Med doi: 10.1002/sim.1013 – volume: 8 start-page: 51 year: 2001 ident: 10.1016/j.bbrc.2014.02.040_b0085 article-title: Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors publication-title: Appl Neuropsychol doi: 10.1207/S15324826AN0801_7 – volume: 9 start-page: 316 year: 1996 ident: 10.1016/j.bbrc.2014.02.040_b0150 article-title: Measurements of Natural Killer (NK) Activity and NK-Cell Quantification publication-title: Methods doi: 10.1006/meth.1996.0037 – volume: 75 start-page: 455 year: 2012 ident: 10.1016/j.bbrc.2014.02.040_b0095 article-title: Evaluation of a Flow Cytometry-Based Assay for Natural Killer Cell Activity in Clinical Settings publication-title: Scand J Immunol doi: 10.1111/j.1365-3083.2011.02667.x – volume: 31 start-page: 3355 year: 2001 ident: 10.1016/j.bbrc.2014.02.040_b0135 article-title: NK cells secrete high levels of IFN-gamma in response to in vivo administration of IL-2 publication-title: Eur J Immunol doi: 10.1002/1521-4141(200111)31:11<3355::AID-IMMU3355>3.0.CO;2-D – volume: 1 start-page: 363 year: 2007 ident: 10.1016/j.bbrc.2014.02.040_b0080 article-title: Physiologic modulation of natural killer cell activity as an index of Alzheimer′s disease progression publication-title: Bioinformation doi: 10.6026/97320630001363 |
| SSID | ssj0011469 |
| Score | 2.3524773 |
| Snippet | •We demonstrated a simple assay of NK cell activity from whole blood.•The measurement of secreted IFN-γ from NK cell enables high-throughput screening.•The NKA... Natural killer (NK) cells are lymphocytes of the innate immune system and have the ability to kill tumor cells and virus-infected cells without prior... Graphical abstract: - Highlights: • We demonstrated a simple assay of NK cell activity from whole blood. • The measurement of secreted IFN-γ from NK cell... |
| SourceID | osti proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 584 |
| SubjectTerms | 60 APPLIED LIFE SCIENCES Adult Aged Aged, 80 and over blood serum CHROMIUM 51 colorectal neoplasms Colorectal Neoplasms - blood Colorectal Neoplasms - immunology COMPARATIVE EVALUATIONS CONCENTRATION RATIO disease surveillance ELISA ENZYME IMMUNOASSAY enzyme-linked immunosorbent assay Enzyme-Linked Immunosorbent Assay - methods ENZYMES Female genetic markers HAZARDOUS MATERIALS High-throughput screening High-Throughput Screening Assays - methods Humans IFN-γ innate immunity INTERFERON interferon-gamma Interferon-gamma - blood Interferon-gamma - immunology Killer Cells, Natural - immunology LYMPHOCYTES Male microsatellite repeats Middle Aged NATURAL KILLER CELLS neoplasm cells NEOPLASMS NK cell activity PATIENTS radionuclides SCREENING Simple assay STIMULATION TUMOR CELLS VIRUSES |
| Title | A high-throughput assay of NK cell activity in whole blood and its clinical application |
| URI | https://dx.doi.org/10.1016/j.bbrc.2014.02.040 https://www.ncbi.nlm.nih.gov/pubmed/24561245 https://www.proquest.com/docview/1508414451 https://www.proquest.com/docview/1825416490 https://www.osti.gov/biblio/22416314 |
| Volume | 445 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swEBYlo2wvY2v3I11XNBh9GVotR5KtxyyspCvLU8vyJnySDSmtE1qH0pf97buz5dDCloe9GFvosKyTpe-k7-4Y-5zbUEgJiUi8HQmFY0rYDEZCggJQOi3zlu3-c2aml-rHXM932KT3hSFaZZz7uzm9na1jyUnszZPVYkE-volJrZyjiZCkNiWPcqUyGuVff29oHuR0GyGwEVQ7Os50HC-AWwpjKFUbt5M2QP6-OA2W-L_9G4O2a9HpK_Yygkg-7tr5mu2U9R7bH9doQN888GPe0jrb_fI9tvutv3s-6ZO77bNfY06BikVM07NaNxxRdPHAlxWfnXPazufk8kCZJfii5veURpe3LHde1IEvmjveO1XyR4fgb9jl6feLyVTEHAvCKyMbYTSgiQhFpdEQUTZDxBJSk1elzr1B6BcAZGYg81oZyCuokiwUoDxgmbXKjt6yQb2sy_eMgzUyoBxeEJaEUW588GkChQ4hFEk6ZLLvXOdjAHLKg3HteqbZlSOFOFKIS1KHChmyLxuZVRd-Y2tt3evMPRlEDteHrXKHpGCSoci5nihGKEToBvtADdmnXvEO1UQqKOpyub5zFExfSYrxtqUO2eBolFp8zbtu1Gw-hU6dEWDpg_9s-Af2gp6IEyfVIRs0t-vyI4KkBo7av-CIPRufnU9nfwDP9A3C |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTmh7QbDxURhgJMQLihanthM_loqpo1ufNtE3KxcnUidIqy3VtP-eu8SpQII-8BJFiU9xfP74nX33O4CPmfW5lBhHcWFHkaI-FdkUR5FEhah0Umatt_vl3Eyv1beFXuzBpI-FYbfKMPd3c3o7W4cnp6E1T9fLJcf4xiaxckEmQpzYJH0E-8xOpQewPz6fTefbwwSaDAIKNhELhNiZzs0L8ZaZDKVqqTt5D-Tv69NgRUPu3zC0XY7OnsKTgCPFuKvqM9gr6yM4HtdkQ_98EJ9E69nZbpkfweMv_d3BpM_vdgzfx4K5iqOQqWe9aQQB6fxBrCoxnwne0Rcc9cDJJcSyFvecSVe0ju4ir71YNneij6sUv52DP4frs69Xk2kU0ixEhTKyiYxGshIxrzTZIsqmBFp8YrKq1FlhCP15RJkaTAutDGYVVnHqc1QF0jNrlR29gEG9qstXINAa6UmOLoRM_CgzhS-SGHPtvc_jZAiyb1xXBA5yToXxw_XOZjeOFeJYIS5OHClkCJ-3MuuOgWNnad3rzP3RjxwtETvlTljBLMPkuQV7GZEQAxxqAzWED73iHamJVZDX5Wpz55hPX0mmedtRhs1wskstfeZl12u2v8IHz4Sx9Ov_rPh7OJheXV64i_P57A0c8ht2kZPqBAbN7aZ8S5ipwXdhTPwCCPYQcw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+high-throughput+assay+of+NK+cell+activity+in+whole+blood+and+its+clinical+application&rft.jtitle=Biochemical+and+biophysical+research+communications&rft.au=Lee%2C+Saet-byul&rft.au=Cha%2C+Junhoe&rft.au=Kim%2C+Im-kyung&rft.au=Yoon%2C+Joo+Chun&rft.date=2014-03-14&rft.issn=0006-291X&rft.volume=445+p.584-590&rft.spage=584&rft.epage=590&rft_id=info:doi/10.1016%2Fj.bbrc.2014.02.040&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-291X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-291X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-291X&client=summon |